SYDNEY, Australia — Apomorphine may represent a novel therapeutic agent to reduce the burden of cognitive impairment in patients with Parkinson's disease (PD). Preliminary findings from a study from ...

Please provide your email address to receive an email when new articles are posted on . 52-week study included 85 adults with Parkinson’s and at least 3 hours/day of “off” time. At week 12, CSAI led ...

In a first of sorts, drugmaker Rusan Pharma is unveiling apomorphine injections in the country, a product that helps tackle fluctuating motor functions in people with Parkinson’s disease. Parkinson’s ...

Apomorphine sublingual film (Kynmobi, Sunovion Pharmaceuticals) was efficacious and generally safe and well tolerated for the on-demand treatment of OFF episodes in Parkinson's disease, long-term ...

Apomorphine, a 150-year-old drug for Parkinson’s disease is found to lower ‘off’ time for people at an advanced stage of the disease. Apomorphine has been in use for many years, but its significance ...

ROCKVILLE, Md., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) today announced that it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) on March ...

Parkinson's is a neurodegenerative disorder that affects millions of people worldwide. This condition is commonly associated with ageing, as it usually affects people 65 years of age and older. But ...

LONDON, March 7, 2017 /PRNewswire/ -- Renown Pharma Limited ("Renown") today announced the results of a pharmacokinetic study intended to compare the plasma concentrations of Renown's sub-lingual ...

Hyderabad: Drug Controller General of India (DCGI) has given licence for new device-aided therapy for Parkinson’s disease. London-based researchers and Nizam’s Institue of Medical Sciences (NIMS) ...

New drug Apomorphine to treat Parkinson’s disease is now available in a Bengaluru hospital. A private hospital in Bengaluru in a tie-up with Britannia Pharmaceuticals, a UK-based pharmaceutical ...